Similarly, DCI supplementation in rats reduced body weight and circulating triglyceride, cholesterol, insulin and fasting glucose levels, while also improving hepatic steatosis, which the authors attributed to activation of the Adiponectin/AMPK/PPAR transcriptional axis in the liver [484]. Here, INS is linked to fatty liver disease.